| ₹ crore | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Revenue | 297 | 233 | +27.5% |
| EBITDA | 70.2 | 62.6 | +12.1% |
| EBITDA margin | 23.6% | 26.9% | −3.2 pts |
| Profit before tax | 45.7 | 39.9 | +14.6% |
| Net profit | 31.3 | 29.0 | +7.9% |
| EPS | ₹2.60 | ₹2.36 | +10.2% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 5,689 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 48.2 | 47.3 | 243 | 395 | 216 | ||
| −2.5 | −1.4 | 0.0 | 0.0 | 0.0 | ||
| 466 | 466 | 178 | 59.5 | 21.5 | ||
| 6,105 | — | — | — | — | ||
| 1,180 | 1,081 | 1,041 | 1,330 | 1,441 | ||
| — | +3.8% | −21.7% | −7.7% | — | ||
| 236 | 239 | 314 | 463 | 634 | ||
| 20.0% | 22.1% | 30.2% | 34.8% | 44.0% | ||
| 142 | 146 | 235 | 392 | 565 | ||
| 97.9 | 105 | 162 | 319 | 383 | ||
| 8.3% | 9.8% | 15.6% | 24.0% | 26.6% | ||
| ₹7.93 | ₹8.54 | ₹13.13 | ₹25.84 | ₹30.99 | ||
| — | −35.0% | −49.2% | −16.6% | — | ||
| — | 140 | 176 | 379 | 496 | ||
| — | −382 | −264 | −131 | −99.9 | ||
| −243 | −243 | −87.3 | 248 | 396 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 5,688.9 | |
| - Cash, Equiv & ST Investments | 216.0 | 395.4 | 242.7 | 47.3 | 48.2 | |
| + Minority Interest | 0.0 | 0.0 | 0.0 | -1.4 | -2.5 | |
| + Total Debt | 21.5 | 59.5 | 178.1 | 466.4 | 466.4 | |
| Enterprise Value | — | — | — | — | 6,104.6 | |
| Revenue | 1,441.1 | 1,330.1 | 1,041.0 | 1,081.1 | 1,180.1 | |
| Growth %, YoY | — | -7.7 | -21.7 | +3.8 | — | |
| EBITDA | 634.0 | 462.7 | 314.2 | 238.8 | 235.6 | |
| Margin % | 44.00 | 34.78 | 30.18 | 22.09 | 19.96 | |
| EBIT | 565.4 | 392.3 | 234.8 | 145.9 | 142.1 | |
| Net Income | 382.6 | 319.0 | 162.1 | 105.4 | 97.9 | |
| Margin % | 26.55 | 23.98 | 15.58 | 9.75 | 8.30 | |
| EPS, Adj (current shares) | 30.99 | 25.84 | 13.13 | 8.54 | 7.93 | |
| Growth %, YoY | — | -16.6 | -49.2 | -35.0 | — | |
| Cash from Operations | 496.1 | 379.3 | 176.2 | 139.6 | — | |
| Capital Expenditures | -99.9 | -131.0 | -263.6 | -382.2 | — | |
| Free Cash Flow | 396.2 | 248.4 | -87.3 | -242.5 | -242.5 | |
Prices at the 29 October 2026 close · figures from the company's filings with NSE
Archean Chemical Industries (NSE: ACI) had a market capitalisation of ₹5,610 crore at the 29 October 2026 close (₹454.40 a share), a PE ratio of 56.9 on the last four quarters' profit and a price-to-book ratio of 2.86. In FY26 its consolidated net profit attributable to shareholders was ₹105 crore on revenue of ₹1,081 crore; in Q2 FY27 (July–September 2026) it was ₹32.1 crore, up 10.2% year on year. Its debt-to-equity ratio was 0.28 on 30 September 2026. Promoters held 53.43% of the shares on 30 September 2026.
Archean Chemical Industries' PE ratio is 56.9 at the 29 October 2026 close (₹454.40 a share): a market capitalisation of ₹5,610 crore divided by consolidated net profit attributable to shareholders of ₹98.6 crore over the last four quarters (Q3 FY26 to Q2 FY27). On FY26 net profit attributable to shareholders (₹105 crore) it is 53.2.
Archean Chemical Industries' price-to-book (PB) ratio is 2.86 at the 29 October 2026 close: a market capitalisation of ₹5,610 crore divided by shareholders' equity (book value) of ₹1,963 crore on 30 September 2026. That is a book value of ₹159.02 per share against a share price of ₹454.40.
Archean Chemical Industries' net worth — shareholders' equity in its consolidated balance sheet — was ₹1,963 crore on 30 September 2026, up 3.1% from ₹1,904 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹5,610 crore at the 29 October 2026 close.
Archean Chemical Industries' market capitalisation was ₹5,610 crore at the 29 October 2026 close: 12.35 crore shares at ₹454.40 each.
No. Archean Chemical Industries had borrowings of ₹551 crore on 30 September 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.28. Its cash and current investments were ₹48.2 crore, so its net debt was ₹503 crore.
Archean Chemical Industries' basic earnings per share (EPS) were ₹8.66 in FY26, against ₹13.13 in FY25. Over the last four quarters (Q3 FY26 to Q2 FY27) they add up to ₹8.13.
Archean Chemical Industries' debt-to-equity ratio was 0.28 on 30 September 2026: borrowings of ₹551 crore against total equity of ₹1,961 crore. A year earlier, on 30 September 2025, it was 0.11.
Archean Chemical Industries' book value per share was ₹159.02 on 30 September 2026: shareholders' equity of ₹1,963 crore divided by the 12.35 crore shares in issue, up 3.1% from ₹154.23 a year earlier. The share price at the 29 October 2026 close was ₹454.40.
Archean Chemical Industries' dividend yield is 0.55% at the 29 October 2026 close: dividends of ₹2.50 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹454.40. They were ₹2.50 on 5 June 2026.
In FY26, Archean Chemical Industries' return on equity (ROE) was 5.6% and its return on capital employed (ROCE) was 6.6%. ROE is net profit attributable to shareholders divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 9.1% and ROCE 11.4%.
On 30 September 2026, Archean Chemical Industries' shares were held by promoters 53.43%, foreign portfolio investors (FII/FPI) 10.41%, domestic institutions (DII) 21.33% (including mutual funds at 15.33%) and retail and other non-institutional investors 14.83%. Over the year, FII holding was down 0.74 percentage points from 11.15% and DII holding was down 4.19 percentage points from 25.52%.
In FY26 (April 2025–March 2026), Archean Chemical Industries' consolidated net profit attributable to shareholders was ₹105 crore, down 35.0% from ₹162 crore in FY25, on revenue from operations of ₹1,081 crore (up 3.8%). Over three years, from FY23, net profit was down 72.4%.
In 2026, Archean Chemical Industries has declared one dividend: ₹2.50 with record date 5 June 2026.
Promoters held 53.43% of Archean Chemical Industries on 30 September 2026, unchanged from the previous quarter and down 0.01 percentage points from 53.44% a year earlier, according to the shareholding pattern filed with NSE.
In FY26, Archean Chemical Industries generated ₹140 crore of cash from operations and spent ₹382 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹243 crore. In FY25 it was −₹87.3 crore.
Archean Chemical Industries' latest results are for Q2 FY27 (July–September 2026), filed on 29 October 2026: consolidated net profit attributable to shareholders ₹32.1 crore, up 10.2% from ₹29.1 crore in Q2 FY26; revenue from operations ₹297 crore, up 27.5% year on year.
Archean Chemical Industries has reported Q2 FY27. Its next results, for Q3 FY27 (October–December 2026), are due by 14 February 2027 under SEBI's 45-day rule; the company notifies the board-meeting date at least two working days before.
In FY26, Archean Chemical Industries earned net profit attributable to shareholders of ₹105 crore on revenue of ₹1,081 crore, against ₹28.8 crore on ₹862 crore for NEOGEN CHEMICALS. Archean Chemical Industries' operating margin was 13.5% (NEOGEN CHEMICALS 12.8%) and its return on equity 5.6% (NEOGEN CHEMICALS 3.6%). At the 29 October 2026 close, Archean Chemical Industries' market capitalisation was ₹5,610 crore against ₹6,193 crore for NEOGEN CHEMICALS, and its PE ratio on FY26 profit 53.2 against 215.4.
From Archean Chemical Industries' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.